Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition

Cisplatin is used as chemotherapeutic drug for oral squamous cell carcinoma (OSCC). However, OSCC cells develop resistance following long-term cisplatin exposure. Resistance against cisplatin chemo-therapy is accredited to the process of epithelial-to-mesenchymal transition, which in-turn has been l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirave, Prathibha, Gondaliya, Piyush, Kulkarni, Bhagyashri, Rawal, Rakesh, Garg, Rachana, Jain, Alok, Kalia, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138164/
https://www.ncbi.nlm.nih.gov/pubmed/32284792
http://dx.doi.org/10.18632/oncotarget.27531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138164/
https://www.ncbi.nlm.nih.gov/pubmed/32284792
http://dx.doi.org/10.18632/oncotarget.27531

Ejemplares similares